IMMUNEVAX
DEAD

Serial Number

99413961

Owner

Stephen John Duncan Bell

First Use Date

Jul 17, 2009

Filing Date

Sep 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNEVAX Trademark

Serial Number: 99413961

IMMUNEVAX is a trademark filed by Stephen John Duncan Bell on September 26, 2025. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Stephen John Duncan Bell

4037 Devonshire Drive
Marietta, GA 30066

Entity Type: 01

Trademark Details

Filing Date

September 26, 2025

Registration Date

Not Registered

First Use Anywhere

July 17, 2009

First Use in Commerce

July 17, 2009

Goods & Services

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Filing History

ABANDONMENT NOTICE E-MAILED - INCOMPLETE RESPONSE
Jul 16, 2026 MAB0
ABANDONMENT - INCOMPLETE RESPONSE
Jun 17, 2026 ABN0
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Apr 1, 2026 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Apr 1, 2026 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Apr 1, 2026 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 30, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 16, 2026 GNFN
FINAL REFUSAL E-MAILED
Mar 16, 2026 GNFR
FINAL REFUSAL WRITTEN
Mar 16, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 6, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 4, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 2, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 26, 2025 MAFR
NEW APPLICATION ENTERED
Sep 26, 2025 NWAP